Gray Market Inflating Cost Of Scarce Drugs, Report Says

Law360, New York (July 26, 2012, 1:33 PM EDT) -- Drug wholesalers are buying up drugs in short supply — such as cancer medication fluorouracil — and reselling them on a gray market, where they can be marked up to nearly 100 times their original price, according to a congressional report released Wednesday.

The report — the result of an investigation initiated by Rep. Elijah Cummings, D-Md., last fall and carried out by Cummings, Sens. Jay Rockefeller, D-W.Va. and Tom Harkin, D-Iowa — found that the wholesalers buy the drugs from licensed pharmacies, or set up...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.